Tumor neoantigen heterogeneity thresholds provide a time window for combination immunotherapy
This paper develops a mathematical framework to show that tumor neoantigen heterogeneity affects immune response, with a diversity threshold beyond which T cells fail to control cancer growth, suggesting a time window for combination immunotherapy.
bioRxiv · Oct 30, 2019 · PreprintCancer Biology